Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells
- PMID: 19265114
- DOI: 10.4049/jimmunol.0801969
Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells
Abstract
Depending upon which TLRs are triggered, dendritic cells (DCs) may orient the differentiation of naive CD4(+) T cells toward either Th1, Th2, regulatory T cells, or the recently defined Th17 lineage. In this study, we report that a dual stimulation of TLR4 and TLR7/8 with LPS plus R848 leads human monocyte-derived DCs (MoDCs) to produce multiple pro- and anti-inflammatory cytokines, including IL-10, IL-12, and IL-23. Surprisingly, a significant variability in the up-regulation of these cytokines is observed in DCs obtained from various healthy donors, with approximately one of three being "high responders." High responding MoDCs stimulated via TLR4 and TLR7/8 induce naive allogeneic CD4(+) T cell to secrete sequentially IL-10 and IFN-gamma, and eventually IL-17A, whereas low responding MoDCs only stimulate IFN-gamma production. Both TLR7 and TLR8 play a central role in this phenomenon: TLR4 triggering with LPS up-regulates TLR7 expression on human MoDCs from high responders, silencing of either TLR7 or TLR8 mRNAs inhibits cytokine production in LPS plus R848-treated MoDCs, and plasmacytoid DCs constitutively expressing high levels of TLR7 induce the production of IL-10, IFN-gamma, and IL-17A by naive T cells when stimulated with R848 alone. Collectively, our results illustrate the synergy between TLR4 and TLR7/8 in controlling the sequential production of regulatory and proinflammatory cytokines by naive CD4(+) T cells. The observed polymorphism in DC responses to such TLR-mediated stimuli could explain differences in the susceptibility to infectious pathogens or autoimmune diseases within the human population.
Similar articles
-
High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production.Surgery. 2006 Aug;140(2):170-8. doi: 10.1016/j.surg.2006.03.006. Surgery. 2006. PMID: 16904966
-
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.J Immunol. 2009 Mar 15;182(6):3928-36. doi: 10.4049/jimmunol.0802226. J Immunol. 2009. PMID: 19265172
-
Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.J Immunol. 2010 Jul 1;185(1):738-47. doi: 10.4049/jimmunol.1000060. Epub 2010 May 28. J Immunol. 2010. PMID: 20511554
-
Induction, function and regulation of IL-17-producing T cells.Eur J Immunol. 2008 Oct;38(10):2636-49. doi: 10.1002/eji.200838535. Eur J Immunol. 2008. PMID: 18958872 Review.
-
Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation.Immunol Rev. 2010 Mar;234(1):90-104. doi: 10.1111/j.0105-2896.2009.00876.x. Immunol Rev. 2010. PMID: 20193014 Review.
Cited by
-
Modulation of immune responses through direct activation of Toll-like receptors to T cells.Clin Exp Immunol. 2010 May;160(2):168-75. doi: 10.1111/j.1365-2249.2010.04091.x. Epub 2010 Jan 29. Clin Exp Immunol. 2010. PMID: 20128825 Free PMC article. Review.
-
Liposomal resiquimod for the treatment of Leishmania donovani infection.J Antimicrob Chemother. 2014 Jan;69(1):168-75. doi: 10.1093/jac/dkt320. Epub 2013 Aug 16. J Antimicrob Chemother. 2014. PMID: 23956375 Free PMC article.
-
Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.J Cancer Res Clin Oncol. 2017 Sep;143(9):1713-1732. doi: 10.1007/s00432-017-2421-7. Epub 2017 Apr 21. J Cancer Res Clin Oncol. 2017. PMID: 28432455 Free PMC article.
-
Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.Acta Pharmacol Sin. 2014 Feb;35(2):219-29. doi: 10.1038/aps.2013.167. Epub 2013 Dec 30. Acta Pharmacol Sin. 2014. PMID: 24374810 Free PMC article.
-
Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma.Oncoimmunology. 2018 Aug 27;7(11):e1500109. doi: 10.1080/2162402X.2018.1500109. eCollection 2018. Oncoimmunology. 2018. PMID: 30377565 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous